Application Deadline:
Opportunity Inquiries:
Explore other Industry Opportunities:
Background
We are a leading brand in hydration solutions, focused on optimizing fluid balance and supporting physical performance and recovery.
The athletic performance space continues to be a growing category for consumer packaged goods (CPG) companies, driven by increasing consumer demand for scientifically supported, performance-enhancing products. While numerous pre- and post-workout solutions exist, there remains a critical need for clinically validated innovations that effectively address key performance and recovery outcomes.
To advance research in this space, we seek to develop clinical trial protocols that assess the efficacy of pre- and post-workout interventions. By establishing scientific methodologies and fostering research collaborations, we aim to generate high-quality, actionable insights that inform product development and enhance athletic performance outcomes.
What we are looking for:
- Increasing the number of people from underserved and underrepresented groups who receive an accurate and timely diagnosis of AD
- Enhancing the provision of guideline-based care and treatment for patients with AD
- Addressing systemic barriers to equitable care throughout the diagnostic and treatment pathway
Eligibility:
We are looking for validated clinical trial protocols designed to assess the effectiveness of pre- and post-workout interventions on key athletic performance outcomes. The ultimate goal is to connect with key opinion leaders in the field and establish a research collaboration to implement validated protocols for testing different interventions.
The protocol should assess muscular power, strength, endurance, cognition, cardiovascular endurance, and fatigue resistance for pre-workout solutions, while measuring muscle recovery, muscle building, and overall physiological recovery for post-workout solutions.
Solutions of interest:
- Clinical trial protocols for outcomes mentioned above
- Unique testing methods for outcomes mentioned above
Must-have requirements:
- Reason to believe the protocol can deliver the targeted outcomes mentioned above
- Compliance with ICH’s Good Clinical Practice (GCP) guidelines
Nice-to-have requirements:
- System/model is adaptable to other health related outcomes such as gut health outcomes and/or blood flow assessments
- Partner has the capability to execute the model on behalf of the company for specified health-related outcomes
Email Swapneeta Date, CTTC Assistant Director of Life Sciences Collaborations, at Swapneeta.Date@Vanderbilt.edu for more information.